AACI/CCAF Annual Meeting
AACI/CCAF Annual Meeting Network with cancer center colleagues, groups, and health agencies to develop solutions to common challenges.
AACI/CCAF Annual Meeting Network with cancer center colleagues, groups, and health agencies to develop solutions to common challenges.
Immuno-Oncology 360° Hear directly from science and business stakeholders on the latest data impacting IO to fight a wider range
2025 ASCO Annual Meeting This conference will bring leading oncology professionals together to connect, inspire, and collaborate.
SCRS Oncology Site Solutions Summit Collaborate with research sites, sponsors, CROs, and solution at the SCRS Oncology Site Solutions Summit
ACCA Cancer Center Administrators Forum This annual meeting brings administrators of NCI-Designated Comprehensive Cancer Centers and those seeking designation together
Oncology trials face unique hurdles in innovation, enrollment, and endpoints, requiring strategic planning to address complex study demands and precision needs.
Phase I oncology trials present distinct ethical challenges, such as participant vulnerability and the risk of therapeutic misconception, requiring careful oversight.
Diversity, equity, and inclusion (DEI) are critical pillars in the evolving landscape of cancer research. These values not only
In Advarra’s recent virtual symposium, experts from industry and academia met to discuss how oncology research has influenced agility in clinical trial design, particularly during the COVID-19 pandemic. Panelists talked about how the COVID-19 pandemic has impacted oncology research and propelled the field’s groundbreaking contributions to research. They also explored ways the pandemic response has shaped the future of oncology research—and research in general.
The COVID-19 pandemic has challenged every aspect of the clinical research industry. This new urgency has affirmed certain clinical trial innovations originally pioneered in the oncology space.
Gene therapy research continues its rapid expansion in the clinical setting, especially in infectious disease, rare disease, and oncology. To support discussion of emerging genetic research issues, Advarra presents its first virtual symposium.
Phase I studies in oncology pose challenges unlike any other early phase study. Most phase I studies begin with healthy volunteers, but because of the unique nature of the trial compounds, participants in oncology phase I studies are typically patients with cancer rather than healthy volunteers.